Pharmacokinetics of the protease inhibitor KNI-272 in plasma and cerebrospinal fluid in nonhuman primates after intravenous dosing and in human immunodeficiency virus-infected children after intravenous and oral dosing
静脉注射给药后,非人灵长类动物血浆和脑脊液中蛋白酶抑制剂KNI-272的药代动力学;静脉注射和口服给药后,人类免疫缺陷病毒感染儿童血浆和脑脊液中蛋白酶抑制剂KNI-272的药代动力学
期刊:Antimicrobial Agents and Chemotherapy
影响因子:4.5
doi:10.1128/AAC.42.7.1815
Mueller, B U; Anderson, B D; Farley, M Q; Murphy, R; Zuckerman, J; Jarosinski, P; Godwin, K; McCully, C L; Mitsuya, H; Pizzo, P A; Balis, F M